AMGN
Amgen Inc.
Stock
$407.27−14.24 (−3.38%)Close Oct 1, 2026
| Operating cash flow (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $12.5B | +3.9% | −1.0% | 0.2% |
| Operating cash flow (TTM) | $12.5B |
|---|---|
| YoY | +3.9% |
| 5-year CAGR | −1.0% |
| 10-year CAGR | 0.2% |
Operating cash flow
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $10.0B | −13.3% |
| 2024 | $11.5B | +35.6% |
| 2023 | $8.5B | −12.9% |
| 2022 | $9.7B | +5.0% |
| 2021 | $9.3B | −11.8% |
| 2020 | $10.5B | +14.7% |
| 2019 | $9.2B | −19.0% |
| 2018 | $11.3B | +1.1% |
| 2017 | $11.2B | +7.9% |
| 2016 | $10.4B | +6.4% |
| 2015 | $9.7B | +8.7% |
| 2014 | $9.0B | +42.3% |
| 2013 | $6.3B | +7.0% |
| 2012 | $5.9B | +14.9% |
| 2011 | $5.1B | −11.5% |
| 2010 | $5.8B | −8.7% |
| 2009 | $6.3B | +5.8% |
| 2008 | $6.0B | +10.9% |
| 2007 | $5.4B | — |